Novavax to raise $200 million through stock offering to fund COVID-19 vaccine
Novavax Inc said on Monday it would raise fresh capital through a $200 million preferred stock offering as it races to develop a vaccine for the new coronavirus, sending its shares up 10.5%. [Source]
Publication Date:Origin: reuters.com
Category: healthNews
Topics: vaccine, offering, stock, through, million, raise, Novavax, shares, sending, coronavirus, develop, races, preferred, capital, fresh, would, COVID-19